Effect of opioid peptide analog on animal behavioral responses under experimental conditions alloxane diabetes mellitus
- Authors: Krintsova Т.А.1, Tsibizova А.А.1, Sergalieva М.U.1, Samotrueva М.А.1
-
Affiliations:
- Astrakhan State Medical University of the Ministry of Health of Russia
- Issue: Vol 27, No 5 (2024)
- Pages: 59-64
- Section: Problems of experimental biology and medicine
- URL: https://journals.eco-vector.com/1560-9596/article/view/633139
- DOI: https://doi.org/10.29296/25877313-2024-05-07
- ID: 633139
Cite item
Open Access
Access granted
Abstract
The aim is to assess the effect of the opioid peptide dalargin on the behavioral responses of laboratory animals under the conditions of experimental alloxane diabetes mellitus.
Material and methods. The experiment was performed on nonlinear white male rats weighing 280-290 g. Laboratory animals were divided into several groups: 1 – control group, which received water for injection daily by intraperitoneal administration (control), 2 – animals with alloxane diabetes mellitus; group 3 – diabetic individuals treated with dalargin for 21 days intraperitoneally at a dose of 100 mkg/kg/day starting one month after alloxan administration. Diabetes mellitus was modeled by intraperitoneal administration of alloxane to pre-starved animals for 24 hours at a dose of 100 mg/kg once (dose worked out in preliminary studies). Assessment of the severity and dynamics of individual behavioral acts, as well as the level of emotional-behavioral reactivity of animals, was carried out using psychopharmacological tests: "Raised cruciform labyrinth" and "Dark light chamber."
Results. When dalargin was administered to animals under the conditions of alloxane diabetes mellitus, an increase in motor activity and cognitive activity was noted, which indicated a decrease in anxiety that was observed during the development of experimental diabetes mellitus.
Conclusion. Based on the results obtained from the study of the effect of the opioid peptide dalargin on the behavioral responses of laboratory animals under the conditions of experimental alloxane diabetes mellitus, it was found that the investigational drug has psychocorregative, antidepressant and anxiolytic effects.
Full Text
About the authors
Т. А. Krintsova
Astrakhan State Medical University of the Ministry of Health of Russia
Author for correspondence.
Email: krintsova@mail.ru
Ph.D. (Pharm.), Associate Professor of the Department of Pharmacognosy, Pharmaceutical Technology and Biotechnology
Russian Federation, AstrakhanА. А. Tsibizova
Astrakhan State Medical University of the Ministry of Health of Russia
Email: krintsova@mail.ru
Ph.D. (Pharm.), Associate Professor of the Department of Pharmacognosy, Pharmaceutical Technology and Biotechnology
Russian Federation, AstrakhanМ. U. Sergalieva
Astrakhan State Medical University of the Ministry of Health of Russia
Email: krintsova@mail.ru
Ph.D. (Biol.), Associate Professor of the Department of Pharmacognosy, Pharmaceutical Technology and Biotechnology
Russian Federation, AstrakhanМ. А. Samotrueva
Astrakhan State Medical University of the Ministry of Health of Russia
Email: krintsova@mail.ru
Dr.Sc. (Med.), Professor, Head of the Department of Pharmacognosy, Pharmaceutical Technology and Biotechnology
Russian Federation, AstrakhanReferences
- Cole, J. B., Florez, J. C. Genetics of diabetes mellitus and diabetes complications. Nature Reviews Nephrology. 2020; 16(7): 377–390. doi: 10.1038/s41581-020-0278-5.
- Lotfi M., Adekwate J., Kalash H., et al. Chronic complications of diabetes mellitus: a mini-review. Current Diabetes Reviews. 2017; 13(1): 3–10.
- Chawla A., Chawla R., Jaggi S. Microvascular and macrovascular complications in diabetes mellitus: distinct or continuous? Indian Journal of Endocrinology and Metabolism. 2016; 20(4): 546. doi: 10.4103/2230-8210.183480.
- Булгаков С.А. Гексапептид даларгин в клинической гастроэнтерологии: 30 лет клинического применения препарата. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016; 26 (3): 103–112. [Bulgakov S.A. Hexapeptide dalargin in clinical gastroenterology: 30 years of clinical use of the drug. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 26 (3): 103–112. (In Russ.)].
- Pencheva N., Bart T. Receptor-selective analogues of en-kephalin. Collection of Czechoslovak Chemical Communi-cations. 2016; 3: 13–18; https://doi.org/10.1135/css199903013.
- Мурталиева В.Х., Цибизова А.А., Сергалиева М.У. и др. Изучение влияния экстракта Astragalus physodes L. на психоэмоциональное состояние животных в условиях «социального» стресса. Дальневосточный медицинский журнал. 2022; 3: 40–46. [Muratalieva V.H., Tsibizova A.A., Sergalieva M.U. et al. Study of the effect of the extract of Astragalus physodes L. on the psycho-emotional state of animals under conditions of "social" stress. Far Eastern Medical Journal. 2022; 3: 40–46. (In Russ.)]. doi: 10.35177/1994-5191-2022-3-7.
- Сергалиева М.У., Цибизова А.А., Абдулкадырова Э.И. и др. Изучение влияния глипролинов на поведение лабораторных животных в условиях экспериментального гипертиреоза. Вестник Российской Военно-медицинской академии. 2021; 23 (4): 179–186. [Sergalieva M.U., Tsibizova A.A., Abdulkadyrova E.I. et al. To study the effect of glyprolins on the behavior of laboratory animals under experimental hyperthyroidism. Bulletin of the Russian Military Medical Academy. 2021; 23 (4): 179-186. (In Russ.)]. doi: 10.17816/brmma66467.
- Симанкова А.А., Сазонова Е.Н., Лебедько О.А. Влияние неонатального введения опиоидного пептида даларгин на отдаленные церебральные последствия антенатальной гипоксии. Патологическая физиология и экспериментальная терапия. 2018; 62(3): 31–36. [Simankova A.A., Sazonova E.N., Lebedko O.A. The effect of neonatal administration of the opioid peptide dalargin on the long-term cerebral consequences of antenatal hypoxia. Pathological physiology and experimental therapy. 2018; 62 (3): 31–36. (In Russ.)]. doi: 10.25557/0031-2991.2018.03.31-36.
- Щербаков Д.Л., Мещанинов В.Н. Перекисный метаболизм клеток и субклеточных структур при стрессе в условиях старения и его коррекция. Здоровье, демография, экология финно-угорских народов. 2017; 3: 77–80. [Shcherbakov D.L., Meshchaninov V.N. Peroxide metabolism of cells and subcellular structures under stress in aging conditions and its correction. Health, demography, ecology of Finno-Ugric peoples. 2017; 3: 77–80. (In Russ.)].
- Донцов А.В. Тревожно-депрессивные расстройства при метаболическом синдроме и возможности их коррекции. Прикладные информационные аспекты медицины. 2013; 16 (1): 31–35. [Dontsov A.V. Anxiety-depressive disorders in metabolic syndrome and the possibility of their correction. Applied information aspects of medicine. 2013; 16 (1): 31–35. (In Russ.)].
- Минина Е.Н., Черетаев И.В. Влияние малых доз даларгина при интраназальном введении на поведение крыс в тесте Порсолта. Крымский журнал экспериментальной и клинической медицины. 2016; 6 (4): 22–26. [Minina E.N., Cheretaev I.V. The effect of small doses of allergen during intranasal administration on the behavior of rats in the Porsolt test. Crimean Journal of Experimental and Clinical Medicine. 2016; 6 (4): 22–26. (In Russ.)].
- Семенова О.Г., Вьюшина А.В., Притворова А.В. и др. Влияние даларгина на изменение тревожности у крыс с различными индивидуально-типологическими особенностями поведения в модели ПТСР. Журнал высшей нервной деятельности им. ИП Павлова. 2021; 71(5): 680–689. [Semenova O.G., Vyushina A.V., Pritvorova A.V., etc. The effect of dalargin on the change in anxiety in rats with different individual and typological features of behavior in the PTSD model. Journal of Higher Nervous Activity named after IP Pavlova. 2021; 71(5): 680-689. (In Russ.)]. doi: 10.31857/S0044467721050099.
- Ярмолинская М.И., Андреева Н.Ю., Абашова Е.И., Мишарина Е.В. Экспериментальные модели сахарного диабета 1-го типа. Журнал акушерства и женских болезней. 2019; 68(2): 109–118. [Yarmolinskaya M.I., Andreyeva N.Yu., Abashova E.I., Misharina E.V. Experimental models of type 1 diabetes. Journal of Obstetrics and Women’s Diseases. 2019; 68(2): 109–118. (In Russ.)]. doi: 10.17816/JOWD682109-118.
Supplementary files
